In the News

• December 2006

  RoundTable Healthcare Partners Makes Additional Equity Investment in Bioniche Pharma

  LAKE FOREST, IL, December 8, 2006 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed its purchase of Bioniche Life Sciences, Inc.’s (“BLSI”, TSX: BNC) 10% ownership stake in Bioniche Pharma Group Limited (“Bioniche Pharma” or the “Company”). RoundTable concurrently made a further equity investment in the Company to support growth initiatives. Financial terms of the BLSI purchase and RoundTable’s incremental equity investment were not disclosed.

  more

• September 2006

  RoundTable Healthcare Partners Acquires Aspen Surgical Products, Inc.

  LAKE FOREST, IL, September 6, 2006 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has acquired a majority interest in Aspen Surgical Products, Inc. (“Aspen”). Aspen, based outside Grand Rapids, Michigan, is a leading manufacturer and marketer of disposable medical products for surgical and general healthcare applications. Daniel J. Bowen, the owner/founder and current President of Aspen, will retain a substantial ownership stake in the company and will continue to help lead the management of the organization. Financial terms of the transaction were not disclosed.

  more

• July 2006

  RoundTable Healthcare Partners Raises $200 Million Subordinated Debt Fund

  LAKE FOREST, IL, July 17, 2006 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today the closing of a captive $200 million subordinated debt fund (the “Capital Fund”). The Capital Fund was initially targeted at $150 million and was oversubscribed by the firm’s existing investors. The employees of RoundTable were the single largest investor in the Capital Fund.

  more

• April 2006

  RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisitions

  LAKE FOREST, IL, April 25, 2006 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced that its portfolio company MedAssist Holding, Inc. (“MedAssist”) has completed the acquisition of Twin Medical Transaction Services, Inc. (“Twin Medical”). Earlier this month, MedAssist separately acquired Capstone Solutions LLC (“Capstone”). Financial terms of the transactions were not disclosed.

  more

• Febraury 2006

  RoundTable Healthcare Partners Announces Sale of American Medical Instruments Holdings, Inc. to Angiotech Pharmaceuticals, Inc.

  LAKE FOREST, IL, February 1, 2006 — RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, American Medical Instruments Holdings, Inc. (“AMIH”), to Angiotech Pharmaceuticals, Inc. (“Angiotech”) for $785 million in cash. Vancouver-based Angiotech (NASDAQ: ANPI, TSX: ANP) is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to create innovative treatments for diseases or to dramatically improve surgical outcomes.

  more

• Febraury 2006

  RoundTable Healthcare Partners Acquires Bioniche Pharma Group Limited

  LAKE FOREST, IL, February 1, 2006 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has acquired a majority interest in Bioniche Pharma Group Limited (“Bioniche Pharma”), the injectable generic pharmaceuticals subsidiary of Bioniche Life Sciences, Inc. (“BLSI”, TSX: BNC). BLSI and the ICC Private Equity Fund (a Fund managed by Bank of Scotland (Ireland) Limited) will each retain reduced minority ownership stakes in the company. The existing Bioniche Pharma management team will also retain an ownership stake in the company and will continue to lead the management of the organization. Financial terms of the transaction were not disclosed.

  more